Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

311
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
311

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GATE Monte Carlo evaluation of cellular dosimetry for <sup>119</sup>Sb in targeted radionuclide therapy.

EJNMMI physics·2026
Same author

Successful Interstitial HDR Brachytherapy for Nasal Skin SCC in Xeroderma Pigmentosum: An Eight-Year Follow-Up Case Report.

Clinical case reports·2026
Same author

An Assessment of Paediatricians' Knowledge and Perspectives of Duchenne Muscular Dystrophy in Oman.

Sultan Qaboos University medical journal·2026
Same author

Folic Acid, Folate Conjugates and Folate Receptors: Novel Applications in Imaging of Cancer and Inflammation-Related Conditions.

Cancer management and research·2025
Same author

Modeling the impact of intercellular signaling on dose metrics and therapeutic outcomes in spatially fractionated radiation therapy (SFRT) for lung cancer.

Scientific reports·2025
Same author

Dose equivalent consideration from neutron contamination in modified radiotherapy vault: a Monte Carlo study.

Biomedical physics & engineering express·2024

Related Experiment Video

Updated: May 16, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.1K

Optimization of the Dose-Volume Effect Parameter "a" in EUD-Based TCP Models for Breast Cancer Radiotherapy.

Farshid Mahmoudi1, Nahid Chegeni2, Ali Bagheri3

  • 1School of Allied Medical Sciences, Lorestan University of Medical Sciences, Khorramabad, Iran.

Technology in Cancer Research & Treatment
|April 1, 2025
PubMed
Summary

Radiobiological models for tumor control probability (TCP) in breast cancer radiotherapy were evaluated. Optimizing the "a" parameter in the Equivalent Uniform Dose (EUD)-based model significantly improved its predictive accuracy compared to clinical outcomes.

Keywords:
Breast Cancer RadiotherapyEUD-based ModelLinear-Poisson ModelRadiobiological ParametersTumor Control Probability (TCP)dose-volume effect

More Related Videos

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.7K
Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.1K

Related Experiment Videos

Last Updated: May 16, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.1K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.7K
Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.1K

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Biostatistics

Background:

  • Traditional radiotherapy planning uses physical dose metrics, neglecting biological impact.
  • Radiobiological models like tumor control probability (TCP) and normal tissue complication probability (NTCP) are crucial for evaluating treatment efficacy and safety.
  • Accurate TCP prediction is vital for optimizing breast cancer radiotherapy outcomes.

Purpose of the Study:

  • To assess the predictive power of radiobiological models for TCP in breast cancer radiotherapy.
  • To provide insights into model selection and parameter optimization for TCP calculations.
  • To compare the performance of Linear-Poisson and Equivalent Uniform Dose (EUD)-based models.

Main Methods:

  • Retrospective observational study of 30 breast cancer patients.
  • Calculation of TCP using Linear-Poisson and EUD-based models with various radiobiological parameter sets.
  • Comparison of model predictions against clinical outcomes from the START trials.

Main Results:

  • The Linear-Poisson model with established parameters showed good agreement with clinical data.
  • The standard EUD-based model (a=-7.2) significantly underestimated TCP.
  • Optimizing the 'a' parameter in the EUD-based model (to -2.57 and -5.65) substantially improved its predictive accuracy.

Conclusions:

  • Clinically relevant radiobiological parameters are essential for accurate TCP prediction.
  • Optimizing the 'a' parameter in the EUD-based model using clinical data enhances its predictive capability for breast cancer radiotherapy.
  • This study highlights the importance of model and parameter refinement for personalized radiotherapy.